THE Therapeutic Goods Administration has added Nplate (romiplostim) to its list of designated orphan drugs.
Amgen's Nplate is indicated for the treatment of chronic immune thrombocytopenic purpura.
The above article was sent to subscribers in Pharmacy Daily's issue from 28 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jun 17